Breadcrumb

Andrea B. Apolo, M.D.

Andrea B. Apolo, M.D.

  • Center for Cancer Research
  • National Cancer Institute
  • Building 10 - Magnuson Clinical Center, Room 13N240
  • Bethesda, MD 20892
  • 301-480-0536
  • 301-480-8867
  • andrea.apolo@nih.gov
Acting Deputy Chief
Genitourinary Malignancies Branch
Senior Investigator
Head, Bladder Cancer Section

RESEARCH SUMMARY

Dr. Apolo is a medical oncologist dedicated to improving the lives of patients with genitourinary tumors.  She designs and implements clinical trials to test novel agents for the treatment of urologic cancers. Her research focuses on developing targeted therapies for bladder cancer and rare genitourinary tumors, including immunotherapies, angiogenesis inhibitors, and agents that target MET, and in identifying molecular alterations that will serve as targets for individualized treatment strategies.

Appointments:  For new patient referrals please contact the Medical Oncology Referral Office, at 240-760-6050 or nciinfo@mail.nih.gov.

Areas of Expertise

Testicular Cancer
Rare Genitourinary Tumors
Targeted Therapy

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them. 

Clinical Trials

Publications

Selected Recent Publications

Determining superior first-line therapy in metastatic bladder cancer

Apolo AB
Nat Rev Urol. 16(12): 698-699, 2019. [ Journal Article ]

Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer

Agrawal S, Haas NB, Bagheri M, Lane BR, Coleman J, Hammers H, Bratslavsky G, Chauhan C, Kim L, Krishnasamy VP, Marko J, Maher VE, Ibrahim A, Cross F Jr, Liu K, Beaver JA, Pazdur R, Blumenthal GM, Singh H, Plimack ER, Choueiri TK, Uzzo R, Apolo AB.
JAMA Oncol. [Epub ahead of print], 2019. [ Journal Article ]

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

Monge C, Maeng H, Brofferio A, Apolo AB, Sathya B, Arai AE, Gulley JL, Bilusic M.
J Immunother Cancer. 6(1): 150, 2018. [ Journal Article ]

Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer

Apolo AB, Milowsky MI, Kim L, Inman BA, Kamat AM, Steinberg G, Bagheri M, Krishnasamy VP, Marko J, Dinney CP, Bangs R, Sweis RF, Maher VE, Ibrahim A, Liu K, Werntz R, Cross F, Beaver JA, Singh H, Pazdur R, Blumenthal GM, Lerner SP, Bajorin DF, Rosenberg JE, Agrawal S.
JAMA Oncol. 1-9, 2019. [ Journal Article ]

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

Patel MR, Ellerton J, Infante JR, Agrawal M, Gordon M, Aljumaily R, Britten CD, Dirix L, Lee KW, Taylor M, Schöffski P, Wang D, Ravaud A, Gelb AB, Xiong J, Rosen G, Gulley JL, Apolo AB.
Lancet Oncol. 19(1): 51-64, 2018. [ Journal Article ]

Job Vacancies

We have no open positions in our group at this time, please check back later.

To see all available positions at CCR, take a look at our Careers page. You can also subscribe to receive CCR's latest job and training opportunities in your inbox.

Team

Photo of Lisa Cordes
Clinical Pharmacist
Lisa Cordes, P.h.D
Patient Care Coordinator
Carlos Diaz
Post Baccalaureate Fellow
Nisha Kalmadi, B.S.
Photo of Andre Kydd
Medical Oncology Fellow
Andre Kydd, M.D.
Research Nurse
Lisa Ley, RN, M.S.
Post Doctoral Fellow
Md Shahid Sarwar, P.h.D
Assistant Research Physician, Dr. Nicholas Simon
Assistant Research Physician
Nicholas Simon, M.D.
Nurse Practitioner
Elizabeth Smith, RN
Research Fellow
Ian Stukes, B.S.
Photo of Tzu-Fang Wang
Research Nurse
Tzu-fang Wang, RN
Photo of Sally Weng
Post Baccalaureate Fellow
Sally Weng, B.S.
Laboratory Technologist
Abbas Yousefi-Rad, M.S.